ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07875
-0,01%
Bitcoin
60.773,80
-0,04%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Advanced Oncotherapy Plc (AVO)

  7. Advanced Oncotherapy Plc (AVO) News

AVO

Advanced Oncotherapy (AVO)

Advanced Oncotherapy Plc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:AVO
DatumZeitQuelleÜberschriftSymbolFirma
09/05/202408h00RNS Regulatory NewsAIM Cancellation - Advanced Oncotherapy PlcLSE:AVOAdvanced Oncotherapy Plc
03/05/202422h30Alliance NewsAlliance NewsIN BRIEF: Advanced Oncotherapy financing talks continue, funds delayedLSE:AVOAdvanced Oncotherapy Plc
03/05/202409h54RNS Regulatory NewsAdvanced Oncotherapy PLC Further update on financing discussionsLSE:AVOAdvanced Oncotherapy Plc
02/04/202418h35Alliance NewsAlliance NewsTRADING UPDATES: Sareum ups retail offer; SThree nabs former ITV execLSE:AVOAdvanced Oncotherapy Plc
02/04/202416h50RNS Regulatory NewsAdvanced Oncotherapy PLC Further update on financing discussionsLSE:AVOAdvanced Oncotherapy Plc
29/02/202419h52Alliance NewsAlliance NewsEARNINGS AND TRADING: Frontier IP sells last of Exscientia holdingLSE:AVOAdvanced Oncotherapy Plc
29/02/202418h19RNS Regulatory NewsAdvanced Oncotherapy PLC Further update on financing discussionsLSE:AVOAdvanced Oncotherapy Plc
02/02/202415h06Alliance NewsAlliance NewsIN BRIEF: Advanced Oncotherapy eyes USD15 million tranche in FebruaryLSE:AVOAdvanced Oncotherapy Plc
01/02/202408h00RNS Regulatory NewsAdvanced Oncotherapy PLC Further update on financing discussionsLSE:AVOAdvanced Oncotherapy Plc
09/01/202415h06Alliance NewsAlliance NewsIN BRIEF: Advanced Oncotherapy in advanced talks regarding loanLSE:AVOAdvanced Oncotherapy Plc
09/01/202410h00UK RegulatoryAdvanced Oncotherapy PLC Update on Financing DiscussionsLSE:AVOAdvanced Oncotherapy Plc
23/10/202319h51Alliance NewsAlliance NewsIN BRIEF: Advanced Oncotherapy in talks over possible cash injectionLSE:AVOAdvanced Oncotherapy Plc
23/10/202308h04UK RegulatoryAdvanced Oncotherapy PLC Update on Financing and Current Financial PositionLSE:AVOAdvanced Oncotherapy Plc
03/10/202319h29Alliance NewsAlliance NewsIN BRIEF: Advanced Oncotherapy results delayed, funding talks continueLSE:AVOAdvanced Oncotherapy Plc
29/09/202317h04UK RegulatoryAdvanced Oncotherapy PLC Update on Financial ResultsLSE:AVOAdvanced Oncotherapy Plc
17/07/202322h41Alliance NewsAlliance NewsAdvanced Oncotherapy plans to raise up to GBP110 millionLSE:AVOAdvanced Oncotherapy Plc
17/07/202308h00UK RegulatoryAdvanced Oncotherapy PLC Recapitalisation and funding plan, update on FSPLSE:AVOAdvanced Oncotherapy Plc
30/06/202320h54Alliance NewsAlliance NewsTRADING UPDATES: Jadestone Energy holds production and capex targetsLSE:AVOAdvanced Oncotherapy Plc
30/06/202318h00UK RegulatoryAdvanced Oncotherapy PLC Total Voting RightsLSE:AVOAdvanced Oncotherapy Plc
30/06/202308h30UK RegulatoryAIM Suspension - Advanced Oncotherapy PLCLSE:AVOAdvanced Oncotherapy Plc
30/06/202308h15UK RegulatoryAdvanced Oncotherapy PLC Update on financing, suspension of trading on AIMLSE:AVOAdvanced Oncotherapy Plc
29/06/202314h35UK RegulatoryAdvanced Oncotherapy PLC Holding(s) in CompanyLSE:AVOAdvanced Oncotherapy Plc
29/06/202310h59UK RegulatoryOdey Asset Management LLP Form 8.3 - Advanced Oncotherapy PLCLSE:AVOAdvanced Oncotherapy Plc
28/06/202311h25UK RegulatoryOdey Asset Management LLP Form 8.3 - Advanced Oncotherapy PLCLSE:AVOAdvanced Oncotherapy Plc
27/06/202311h29UK RegulatoryOdey Asset Management LLP Form 8.3 - Advanced OncotherapyLSE:AVOAdvanced Oncotherapy Plc
27/06/202311h25UK RegulatoryOdey Asset Management LLP Form 8.3 - Advanced OncotherapyLSE:AVOAdvanced Oncotherapy Plc
26/06/202317h35UK RegulatoryOdey Asset Management LLP Form 8.3 - Advanced OncotherapyLSE:AVOAdvanced Oncotherapy Plc
26/06/202311h57UK RegulatoryAdvanced Oncotherapy PLC Partial conversion of Convertible NotesLSE:AVOAdvanced Oncotherapy Plc
23/06/202312h05UK RegulatoryAdvanced Oncotherapy PLC Holding(s) in CompanyLSE:AVOAdvanced Oncotherapy Plc
23/06/202310h30UK RegulatoryOdey Asset Management LLP Form 8.3 - Advanced Oncotherapy PLCLSE:AVOAdvanced Oncotherapy Plc
 Showing the most relevant articles for your search:LSE:AVO

Kürzlich von Ihnen besucht

DBI
MDAX
MDAX
CCOM
US30
US 30
CCOM
US500
US 500
NASDAQ
AAPL
Apple
AMEX
SPY
SPDR S&P 500
NYSE
NKE
Nike
TG
NOV
Novo Nordisk
USOTC
BASFY
BASF (QX)
PM
XAUUSD
Gold vs US Dollar
TG
DBK
Deutsche Bank
NASDAQ
MSFT
Microsoft
NYSE
MCD
McDonalds
USOTC
RHHBY
Roche (QX)
FX
EURUSD
Euro vs US Dollar
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten